Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Edgewise Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 226
- +15 vs. Q1 2026
- Shares held
- 119.2M
- +6.59M (+5.9%) vs. Q1 2026
- Total value
- $4.82B
- +$1.29B (+36.4%) vs. Q1 2026
- New holders
- 42
- 83 more added
- Sold out
- 27
- 73 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Victory Capital Management Inc | 902,870 | $36.7M | 0.02% | +113,827+14.4% | Added |
| First Light Asset Management, LLC | 1,095,171 | $44.5M | 2.70% | +93,325+9.3% | Added |
| American Century Companies Inc | 1,127,078 | $45.8M | 0.02% | −20,098−1.8% | Reduced |
| Dimensional Fund Advisors LP | 1,139,726 | $46.3M | 0.01% | −79,991−6.6% | Reduced |
| Qube Research & Technologies Ltd | 1,252,507 | $50.9M | 0.06% | +426,597+51.7% | Added |
| Bank of America Corp | 1,558,260 | $63.3M | 0.00% | +230,900+17.4% | Added |
| MPM Oncology Impact Management LP | 1,620,780 | $65.9M | 4.02% | −39,916−2.4% | Reduced |
| Alliancebernstein L.P. | 2,119,024 | $66.7M | 0.02% | +396,855+23.0% | Added |
| State Street Corp | 1,827,927 | $74.3M | 0.00% | +111,104+6.5% | Added |
| Morgan Stanley | 1,948,597 | $79.2M | 0.00% | −297,431−13.2% | Reduced |
| Braidwell LP | 1,996,965 | $81.1M | 3.00% | −350,618−14.9% | Reduced |
| Integral Health Asset Management, LLC | 2,000,000 | $81.3M | 3.33% | +400,000+25.0% | Added |
| Geode Capital Management, LLC | 2,174,051 | $88.3M | 0.00% | +384,232+21.5% | Added |
| Cormorant Asset Management, LP | 2,510,000 | $102.0M | 5.23% | −750,000−23.0% | Reduced |
| Siren, L.L.C. | 3,184,629 | $129.4M | 2.63% | −1,245,634−28.1% | Reduced |
| Baker Bros. Advisors LP | 3,701,719 | $150.4M | 0.75% | −2,874,221−43.7% | Reduced |
| Vanguard Capital Management LLC | 3,860,670 | $156.9M | 0.00% | +72,509+1.9% | Added |
| Perceptive Advisors LLC | 4,373,974 | $177.7M | 2.76% | −50,000−1.1% | Reduced |
| Driehaus Capital Management LLC | 4,728,623 | $192.1M | 1.11% | +250,681+5.6% | Added |
| Novo Holdings A/S | 5,350,000 | $217.4M | 12.67% | 00.0% | Unchanged |
| FMR LLC | 5,489,135 | $223.0M | 0.01% | +4,472,083+439.7% | Added |
| Jupiter Topco LLC | 6,075,331 | $246.9M | 0.10% | +6,075,331 | New |
| BlackRock, Inc. | 6,606,336 | $268.4M | 0.00% | +133,345+2.1% | Added |
| Ra Capital Management, L.P. | 8,392,730 | $341.0M | 2.96% | −2,035,707−19.5% | Reduced |
| Paradigm Biocapital Advisors LP | 10,215,455 | $415.1M | 7.77% | +2,850,417+38.7% | Added |
| OrbiMed Advisors LLC | 15,518,492 | $630.5M | 11.94% | 00.0% | Unchanged |
| Bellevue Group AG | 0 | $0 | 0.00% | −1,528,518−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −447,416−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −342,867−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −290,864−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −268,986−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −200,661−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −149,863−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −148,426−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −145,286−100.0% | Sold out |
| Ishara Investments LP | 0 | $0 | 0.00% | −49,200−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −46,401−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −42,615−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −38,675−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −13,767−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −12,930−100.0% | Sold out |
| Seven Fleet Capital Management LP | 0 | $0 | 0.00% | −11,701−100.0% | Sold out |
| SFMG, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Elmind Capital, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −9,941−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −3,804−100.0% | Sold out |
| Cygnus Capital Advisors, LLC | 0 | $0 | 0.00% | −3,427−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,832−100.0% | Sold out |
| Winthrop Capital Management, LLC | 0 | $0 | 0.00% | −1,377−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −678−100.0% | Sold out |
| Eastern Bank | 0 | $0 | 0.00% | −223−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| Skopos Labs, Inc. | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |